The Research and Recognition Project brings together international academics, researchers and therapists to examine the current evidence of the clinical efficacy of RTM techniques, considering how it can be effective in facilitating change, enrichment and symptom relief.
Dr. Frank Bourke and his colleagues provide a critical appraisal of evidence-based research in the area to indicate the benefits of the approach and identify the need for an increase in randomized well-controlled clinical trials.
Pilot Study published in the Journal of Military, Veteran, and Family Health, (NY $300,000 Pilot). 25 of 26 (96%) no longer test as having PTSD and their PTS behavioral symptoms were fully alleviated in under five sessions. (Gray and Bourke, 2015)
First Replication Study. Results have been submitted for peer Journal Publication. Over 94% of the 30 male veterans were symptom and diagnosis free at the two-week, six-week, and six-month follow-ups.
Second Replication Study. Results have been submitted for peer -reviewed Journal Publication. Over 96% of the 30 women veterans have scored below diagnostic threshold on the PCL-M at two weeks post and six-week follow-ups.
Third Replication Study. (NY $800 K Grant). 2016 75 veteran study has been completed and is being prepared for publication in 2016. Over 90% of the male veterans completing treatment have scored below diagnostic threshold on the PCL-M at two weeks post treatment.
Neurological Studies using EEG, pre- and post-treatment, have begun at the University of New Mexico. Two pilots are being paid for by New Mexico R & R supporters and are expected to be completed in 2016. Initial pre-pilot results are below.
Pre RTM Treatment Baseline qEEG
5 Days Post-RTM Treatment qEEG
The graph below shows the results of the first three RTM studies. All three remit PTSD Diagnosis above 88% and these results are maintained out to the six months measured. The fourth study of VA approved treatments by Steenkamp in JAMA 2015 shows less than 35% diagnosis remission and contains a 25% dropout rate.
Click image to enlarge.
As can be seen in the previous graph, all three of the initial RTM studies show loss of diagnosis after treatment above 88% with no significant drop outs and on the graph below the results are maintained for six months.